Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.715697
Title: Development of a biorelevant dynamic model of human proximal colon : a tool for designing colon-specific drug delivery systems
Author: Stamatopoulos, Konstantinos
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2017
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
A novel Dynamic Colon Model (DCM) that represents the anatomy and physiology of the human proximal colon was developed. Analysis of the hydrodynamics was performed using Positron Emission Particle Tracking (PEPT) system and Positron Emission Tomography (PET). The pressures generated by the wall motion of the DCM tube compared with the available published in vivo data. The hydrodynamics in USP 2 dissolution apparatus were also assessed using Particle Image Velocimetry (PIV) and Planar Induced Fluorescence (PLIF). Areal distribution and individual striation methods showed high mixedness level close to tip. PEPT experiments were performed using particles of different buoyancy. Use of different particles gave different results in terms of velocities and residence times within the DCM tube. PET images showed that antegrade propagating waves of amplitude lower than the minimum threshold used in vivo studies were associated with flow episodes. In addition, flow episodes can occur which are not related to the wall motion. Dissolution profiles of theophylline, a high water soluble drug, released from a hydrophilic matrix obtained at viscous shear thinning media, mimicking the dewatering process in the human colon. The novel DCM provides a realistic colonic environment, enabling biorelevant in vitro assessment of the in vivo performance of dosage forms.
Supervisor: Not available Sponsor: Engineering and Physical Sciences Research Council
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.715697  DOI: Not available
Keywords: RC Internal medicine ; TP Chemical technology
Share: